Article

Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era

Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas, USA.
Gastroenterology (Impact Factor: 16.72). 06/2009; 136(6):2015-31. DOI: 10.1053/j.gastro.2009.01.072
Source: PubMed

ABSTRACT

Studies of metagenomics and the human microbiome will tremendously expand our knowledge of the composition of microbial communities in the human body. As our understanding of microbial variation and corresponding genetic parameters is refined, this information can be applied to rational remodeling or "tailoring" of human-associated microbial communities and their associated functions. Physiologic features such as the development of innate and adaptive immunity, relative susceptibilities to infections, immune tolerance, bioavailability of nutrients, and intestinal barrier function may be modified by changing the composition and functions of the microbial communities. The specialty of gastroenterology will be affected profoundly by the ability to modify the gastrointestinal microbiota through the rational deployment of antibiotics, probiotics, and prebiotics. Antibiotics might be used to remove or suppress undesirable components of the human microbiome. Probiotics can introduce missing microbial components with known beneficial functions for the human host. Prebiotics can enhance the proliferation of beneficial microbes or probiotics, to maximize sustainable changes in the human microbiome. Combinations of these approaches might provide synergistic and effective therapies for specific disorders. The human microbiome could be manipulated by such "smart" strategies to prevent and treat acute gastroenteritis, antibiotic-associated diarrhea and colitis, inflammatory bowel disease, irritable bowel syndrome, necrotizing enterocolitis, and a variety of other disorders.

Download full-text

Full-text

Available from: James Versalovic
  • Source
    • "Furthermore, as mentioned before, Src family kinase-induced phosphorylation of tyrosine causes, among others, MAP kinase signalling (Goodridge et al., 2009; Huysamen and Brown, 2009). Additionally, teleost IgT that is associated with gut mucosal surfaces has immunoprotective roles (Zhang et al., 2011), and in mammals immunomodulins induce TGF-b, APRIL and BAFF to simulate lymphocytes to produce IgA (Preidis and Versalovic, 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Atlantic salmon was orally intubated with a highly purified β-glucan product (MacroGard®) to study the recognition of the molecule by the receptor genes, the regulation of the downstream signalling genes and global proteins, and the micromorphological changes in the intestine. The β-glucan receptor genes of Atlantic salmon, sclra, sclrb, sclrc and cr3, seem to recognize the molecule, and initiate the downstream ITAM-motif signalling, as evident from the significantly high mRNA levels of ksyk, mapkin2, il1b and mip2a levels. Among the altered proteins, the Apoa4 (involved in carbohydrate and lipid metabolism); Tagln, Actb (uptake of β-glucan); Psma2 (associated with substrate recognition); and Ckt (energy metabolism-related) were the overexpressed ones. The underexpressed proteins included the Uk114, Rpl9, Ctsb and Lgal that are connected to proliferation, LPS-stimulation, Il1b and lactose recognition, respectively. Furthermore, the mRNA levels of igt and the number of immune cells in the distal intestine were found to increase upon β-glucan uptake by the fish. This study provides some clues on the mechanisms by which the β-glucan evokes response in Atlantic salmon, particularly at the intestinal level.
    Full-text · Article · Nov 2015 · Developmental and comparative immunology
    • "The biochemical activities of the non-xenobiotics are usually facilitated via the production of short-chain fatty acids such as acetates and butyrates with function specific to acetylated lysines and lysine deacetylase enzymes, respectively [9]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: It is now very much clear that the microbiome plays an important part in human health. Microbiome is associated with several diseases and targeting the whole microbiome is certainly a challenge before the scientists. The "Human Microbiome Project" is continually exploring certain therapeutic targets inside microbiome landscape that could be utilized for the treatment of microbiome associated diseases. Additionally, associated research across the globe is going on and now some potential targets are available that might be beneficial for the designing and synthesis of novel drugs. In this review, we made an effort to discuss all the potential targets and corresponding possible drugs/treatments available for each of them. However, it is not possible to treat all microbiome associated diseases with a single drug/drug combination. Therefore, for different diseases, different treatments/drugs (whether xenobiotic or non-xenobiotic) could be used for better therapeutic efficacy.
    No preview · Article · Sep 2015 · Current Drug Metabolism
  • Source
    • "The susceptibility of existing biofilms to invasion by planktonic cells can be expected to influence the spatial and temporal arrangement of cells in biofilms , as well as their strain and species composition (Amarasekare and Nisbet, 2001). These biofilm properties, in turn, will have ramifications on the evolution of bacterial behavior, for example, investment into local competition versus dispersal (Hanski et al., 2011), and potentially for the development of novel probiotic strategies for enhancing or inhibiting biofilms (Preidis and Versalovic, 2009; Rendueles et al., 2013). Invasion dynamics will also influence the evolutionary stability of extracellular matrix production (Xavier and Foster, 2007; van Gestel et al., 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Many bacteria are highly adapted for life in communities, or biofilms. A defining feature of biofilms is the production of extracellular matrix that binds cells together. The biofilm matrix provides numerous fitness benefits, including protection from environmental stresses and enhanced nutrient availability. Here we investigate defense against biofilm invasion using the model bacterium Vibrio cholerae. We demonstrate that immotile cells, including those identical to the biofilm resident strain, are completely excluded from entry into resident biofilms. Motile cells can colonize and grow on the biofilm exterior, but are readily removed by shear forces. Protection from invasion into the biofilm interior is mediated by the secreted protein RbmA, which binds mother-daughter cell pairs to each other and to polysaccharide components of the matrix. RbmA, and the invasion protection it confers, strongly localize to the cell lineages that produce it.The ISME Journal advance online publication, 20 January 2015; doi:10.1038/ismej.2014.246.
    Full-text · Article · Jan 2015 · The ISME Journal
Show more